| Authors: |
Diorio C; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA DIORIOC@chop.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Shraim R; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Thadi A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Frank-Kamenetskii A; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Uppuluri L; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Klinghoffer H; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Martinez Z; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Babu A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Myers RM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fraietta JA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hughes A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sussman J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Xu J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., McClory SE; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Mueller K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Perazzelli J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Vella LA; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Henrickson SE; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Ruella M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Behrens EM; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., DiNofia AM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Burkhardt JK; Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Maude SL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Canna S; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Tan K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Grupp S; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Teachey DT; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
